ADIA – The Abu Dhabi Investment Authority, one of the world’s largest sovereign wealth funds, has announced a strategic investment of USD 200 million in Meril, India’s fast-growing medical device company valued at USD 6.6 billion. This landmark investment underscores ADIA’s confidence in India’s expanding healthcare sector and Meril’s potential to become a global leader in medical technology.
Meril, headquartered in Vapi, Gujarat, has rapidly emerged as a prominent innovator in the medical device industry with a broad portfolio spanning cardiovascular devices, orthopedics, and surgical equipment. The company’s commitment to cutting-edge research and development, alongside its robust manufacturing capabilities, has positioned it as a vital player in India’s healthcare ecosystem and an increasingly influential exporter to global markets.
The capital infusion from ADIA will enable Meril to accelerate its product innovation pipeline, expand manufacturing capacity, and strengthen its international footprint. This partnership aligns with India’s national vision to boost domestic medical device production and reduce import dependency, thereby enhancing healthcare accessibility and affordability across the country.
Dr. Arun Garg, Founder and Chairman of Meril, expressed enthusiasm about the collaboration, stating that the company is honored to welcome ADIA as a strategic partner. He noted that the investment validates Meril’s vision to pioneer advanced medical technologies aimed at improving patient outcomes globally. With ADIA’s support, Meril plans to accelerate growth and innovation, driving transformative change in healthcare.
Ahmed Al Dhaheri, Senior Managing Director at ADIA, highlighted that India’s healthcare market offers compelling long-term growth opportunities. He noted that Meril’s strong leadership, technology-driven approach, and alignment with India’s healthcare priorities position the company as an ideal investment. He expressed ADIA’s commitment to supporting Meril’s journey toward becoming a global medical device powerhouse.
Also Read: DoH Launches Operations at its Regional Vaccine Distribution Hub.
This investment marks one of ADIA’s largest commitments in India’s medical device sector, reflecting growing global investor interest in healthcare innovation in emerging markets. The partnership between ADIA and Meril is expected to create significant value for stakeholders and contribute meaningfully to the development of India’s healthcare infrastructure.
